Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0021665,
umls-concept:C0024501,
umls-concept:C0032821,
umls-concept:C0037083,
umls-concept:C0037657,
umls-concept:C0038952,
umls-concept:C0044602,
umls-concept:C0521390,
umls-concept:C0721534,
umls-concept:C1314939,
umls-concept:C1704259,
umls-concept:C1705987,
umls-concept:C1710082,
umls-concept:C2936824
|
pubmed:issue |
5
|
pubmed:dateCreated |
1997-3-26
|
pubmed:abstractText |
Cultured cerebellar granule neurons die by apoptosis when switched from a medium containing an elevated level of potassium (K+) to one with lower K+ (5 mM). Death resulting from the lowering of K+ can be prevented by insulin-like growth factor (IGF-1). To understand how IGF-1 inhibits apoptosis and maintains neuronal survival, we examined the role of phosphoinositide 3-kinase (PI 3-kinase). Activation of PI 3-kinase has been shown previously to be required for NGF-mediated survival in the PC12 pheochromocytoma cell line. We find that in primary neurons, IGF-1 treatment leads to a robust activation of PI 3-kinase, as judged by lipid kinase assays and Western blot analysis. Activation of PI 3-kinase is likely to occur via tyrosine phosphorylation of the insulin receptor substrate protein. Treatment with two chemically distinct inhibitors of PI 3-kinase, wortmannin and LY294002, reduces PI 3-kinase activation by IGF-1 and inhibits its survival-promoting activity, suggesting that PI 3-kinase is necessary for IGF-1-mediated survival. Death resulting from PI 3-kinase blockade is accompanied by DNA fragmentation, a hallmark of apoptosis. Furthermore, neurons subjected to PI 3-kinase blockade can be rescued by transcriptional and translation inhibitors, suggesting that IGF-1-mediated activation of PI 3-kinase leads to a suppression of "killer gene" expression. In sharp contrast to IGF-1, elevated K+ does not activate PI 3-kinase and can maintain neuronal survival in the presence of PI 3-kinase inhibitors. Therefore, survival of granule neurons can be maintained by PI 3-kinase dependent (IGF-1-activated) and independent (elevated K+-activated) pathways.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Androstadienes,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphotransferases (Alcohol Group...,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/wortmannin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0270-6474
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1548-60
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9030615-Androstadienes,
pubmed-meshheading:9030615-Animals,
pubmed-meshheading:9030615-Apoptosis,
pubmed-meshheading:9030615-Cerebellar Cortex,
pubmed-meshheading:9030615-Enzyme Inhibitors,
pubmed-meshheading:9030615-Gene Expression Regulation,
pubmed-meshheading:9030615-Insulin-Like Growth Factor I,
pubmed-meshheading:9030615-Nerve Tissue Proteins,
pubmed-meshheading:9030615-Neurons,
pubmed-meshheading:9030615-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:9030615-Phosphotransferases (Alcohol Group Acceptor),
pubmed-meshheading:9030615-Potassium,
pubmed-meshheading:9030615-Rats,
pubmed-meshheading:9030615-Rats, Wistar,
pubmed-meshheading:9030615-Signal Transduction
|
pubmed:year |
1997
|
pubmed:articleTitle |
Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3-kinase in IGF-1 signaling.
|
pubmed:affiliation |
Department of Physiology and Neurobiology, University of Connecticut, Storrs, Connecticut 06269, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|